恶性疾病继发淋巴水肿合并髂股静脉梗阻患者髂股静脉支架置入的疗效
回顾性分析2012年7月至2020年12月在本机构因髂股静脉梗阻合并恶性肿瘤继发淋巴水肿接受静脉支架置入的53例患者,12个月随访显示Villalta评分和慢性静脉疾病生活质量问卷评分均显著改善,累积一期、辅助一期和二期通畅率分别为70.8%、76.9%和90.1%。
要点
- 53例恶性肿瘤继发淋巴水肿合并髂股静脉梗阻患者接受静脉支架置入,即刻技术成功率100%。
- Villalta评分中位数从基线12降至12个月时5,生活质量问卷评分从58降至28(P<.05)。
- 中位随访12个月,累积一期、辅助一期和二期通畅率分别为70.8%、76.9%和90.1%。
核心结论
- 在恶性肿瘤继发淋巴水肿患者中,静脉支架置入治疗髂股静脉梗阻安全有效。
研究设计与样本
- 回顾性研究,纳入2012年7月至2020年12月在本机构接受静脉支架置入的髂股静脉梗阻合并继发性淋巴水肿患者53例,其中女性42例,平均年龄56.9岁。
主要发现
- 非血栓性髂静脉病变16例(30.1%),即刻技术成功率100%,平均置入2枚支架。
- Villalta评分中位数从基线12(IQR 10-15)降至术后12个月5(IQR 4-6),慢性静脉疾病生活质量问卷评分从58(IQR 50-66)降至28(IQR 22-45),P<.05。
- 中位随访12个月(范围3-25个月),累积一期、辅助一期和二期通畅率分别为70.8%、76.9%和90.1%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the safety and effectiveness of venous stenting in patients with chronic iliofemoral venous obstruction and secondary lymphedema from malignancy. METHODS: From July 2012 to December 2020, patients with iliofemoral venous obstruction and secondary lymphedema who underwent venous stenting in our institution were reviewed retrospectively. Clinical characteristics, surgical complications, and symptom relief were assessed. Stent patency was evaluated with duplex ultrasound or computed tomographic venography. Twelve-month outcomes were reported. RESULTS: Fifty-three patients with concurrent secondary lymphedema who had stents placed for iliofemoral venous obstruction were included. There were 42 females, and the mean age was 56.9 years. Nonthrombotic iliac vein lesions were identified in 16 patients (30.1%). Immediate technical success was 100%, with an average of two stents implanted. The median Villalta score, and Chronic Venous Disease Quality of Life quality of life questionnaire scores decreased from 12 (IQR, 10-15) and 58 (IQR, 50-66) at baseline, respectively, to 5 (interquartile range [IQR], 4-6) and 28 (IQR, 22-45) at 12 months after the procedure (P < .05), showing significant improvement in the quality of life. At the end of a median follow-up of 12 months (range, 3-25 months), the cumulative primary, assisted primary, and secondary patency rates were 70.8%, 76.9%, and 90.1%, respectively. CONCLUSIONS: In patients with secondary lymphedema from malignancy, venous stent placement is safe and effective for iliofemoral venous obstruction.
引用
- Li X, Wang Z, Jing Z, et al. The efficacy of stenting in the iliofemoral vein of patients with venous obstruction and secondary lymphedema from malignancy. J Vasc Surg Venous Lymphat Disord. 2023. PMID: 36787860. doi:10.1016/j.jvsv.2023.01.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。